Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NPS Pharmaceuticals updates plans for Natpara BLA

Sep. 6, 2012

Light study of Contrave experiences accelerated enrollment

Sep. 6, 2012

Novel monoclonal antibodies patented by IRM and Novartis

Sep. 6, 2012

BioSante Pharmaceuticals reports phase III safety data for LibiGel

Sep. 5, 2012

Stem cell gene therapy improves erectile dysfunction in rats

Sep. 5, 2012

New series of GPR119 agonists optimized by Bristol-Myers Squibb

Sep. 4, 2012

Silodosin evaluated for premature ejaculation

Sep. 4, 2012

Novo Nordisk gives update on approval of insulin degludec in Japan

Sep. 3, 2012

Bristol-Myers Squibb profiles novel MCH1 receptor antagonist

Sep. 3, 2012

Mechanism of action of epelsiban besilate further elucidated

Sep. 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...